Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04522388 · ClinicalTrials.gov registry record · NA

Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT04522388: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT04522388 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04522388, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

This non-randomized pilot study aims to investigate whether a protein rich nutritional shake (Ensure Enlive) given to patients pre-transplant will decrease skeletal muscle loss (measured by quadriceps ultrasound) and improve nutritional state (measured by Nutritional Risk Index). A nutritional supplement would be a cost-effective solution to treat malnutrition, a known risk factor implicated in poor outcomes for lung transplant recipients.

Interventions

  • DIETARY_SUPPLEMENT Ensure Enlive

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2023-09-01
Est. Completion 2024-01-08
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT04522388

The ClinicalTrials.gov registry entry for NCT04522388 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ensure Enlive is the first listed.

NCT04522388 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04522388 about?

NCT04522388 is a clinical study titled "Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant". This non-randomized pilot study aims to investigate whether a protein rich nutritional shake (Ensure Enlive) given to patients pre-transplant will decrease skeletal muscle loss (measured by quadriceps ultrasound) and improve nutritional state (measured by Nutritional Risk Index). A nutritional suppl...

What is the current status of trial NCT04522388?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-09-01. Estimated completion is 2024-01-08.

What interventions are being tested in trial NCT04522388?

The interventions under investigation include: Ensure Enlive (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04522388?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.